Progress of anti-tumor mechanism of arsenic / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 146-149, 2021.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-886023
Responsible library:
WPRO
ABSTRACT
The arsenic compounds including arsenic trioxide and arsenic sulfide have played a crucial role in the clinical treatment of hematologic malignancies and solid tumors. Arsenic agents can induce tumor cells differentiation, apoptosis and autophagy, eliminate leukemia-initiating cells, and directly bind to the target proteins. This paper reviews the mechanism progress of arsenic agents in various tumors to further understand the intricate anti-tumor mechanisms of arsenic agents and to expand its therapeutic spectrum.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research and Clinic
Year:
2021
Document type:
Article